Cargando…

Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2′-O-Methyl Mixmer Antisense Oligonucleotide

In this study, we synthesised a morpholino nucleoside-uridine (MNA-U) phosphoramidite and evaluated the potential of a MNA-modified antisense oligonucleotide (AO) sequences to induce exon 23 skipping in mdx mouse myotubes in vitro towards extending the applicability of morpholino chemistry with othe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Suxiang, Le, Bao T., Rahimizadeh, Kamal, Shaikh, Khalil, Mohal, Narinder, Veedu, Rakesh N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274534/ https://www.ncbi.nlm.nih.gov/pubmed/27879669 http://dx.doi.org/10.3390/molecules21111582

Ejemplares similares

Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
por: Chen, Suxiang, et al.
Publicado: (2019)

Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice
por: Wang, Mingxing, et al.
Publicado: (2015)

Author Correction: Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
por: Chen, Suxiang, et al.
Publicado: (2020)

Mna-made black holes?
por: Ripley, Sebastian
Publicado: (2006)

Synthesis of Backbone-Modified Morpholino Oligonucleotides Using Phosphoramidite Chemistry
por: Paul, Sibasish, et al.
Publicado: (2023)

Rational Design of Short Locked Nucleic Acid-Modified 2′-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In Vitro
por: Le, Bao T., et al.
Publicado: (2017)

Polyquaternium-mediated delivery of morpholino oligonucleotides for exon-skipping in vitro and in mdx mice
por: Wang, Mingxing, et al.
Publicado: (2017)

Exon-skipping antisense oligonucleotides for cystic fibrosis therapy
por: Kim, Young Jin, et al.
Publicado: (2022)

MNA2.1 - Project web presence
Publicado: (May )

MNA2.2.1 - Dissemination material
Publicado: (July)

MNA2.2.2 - Dissemination material
por: Members of the EMI Collaboration
Publicado: (Apri)

MNA2.2.3 - Dissemination material
por: Members of the EMI collaboration, et al.
Publicado: (Apri)

CONGENIC STRAIN DIFFERENCES OF RENAL MALFORMATIONS IN ACI/MNA RATS BY INTROGRESSION OF THE CHROMOSOMAL REGION OF BUF/MNA RATS CONTAINING PUR1
por: MATSUYAMA, MUTSUSHI, et al.
Publicado: (2013)

MNA1.1 - Project Kick-Off Meeting
Publicado: (May )

Specific RNP capture with antisense LNA/DNA mixmers
por: Rogell, Birgit, et al.
Publicado: (2017)

Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD
por: Akpulat, Ugur, et al.
Publicado: (2018)

MNA1.2 - Project management information system and tools
Publicado: (May )

MNA1.4.1 - Service Level Agreements in place
Publicado: (Octo)

MNA1.4.2 - Service Level Agreements in place
por: Members of EMI collaboration
Publicado: (Octo)

MNA1.4.3 - Service Level Agreements in place
Publicado: (Apri)

MNA2.3.1 - Training material and on-line courses
Publicado: (Octo)

MNA2.3.2 - Training material and on-line courses
por: Members of EMI collaboration
Publicado: (Octo)

MNA2.3.3 - Training material and on-line courses
Publicado: (Octo)

Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries
por: Adams, Abbie M, et al.
Publicado: (2007)

Proof-of-Concept: Antisense Oligonucleotide Mediated Skipping of Fibrillin-1 Exon 52
por: Cale, Jessica M., et al.
Publicado: (2021)

Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy
por: van Deutekom, Judith, et al.
Publicado: (2023)

MNA1.5.1 -Successful completion of the periodic and final reviews
por: Members of EMI collaboration
Publicado: (June)

MNA1.5.2 -Successful completion of the periodic and final reviews
Publicado: (June)

MNA1.5.3 -Successful completion of the periodic and final reviews
Publicado: (Apri)

MNA1.3 - Technical collaboration procedures with EGI and PRACE are established
Publicado: (July)

MNA3.2 - Open Source Software Initiative Charter exists
Publicado: (Marc)

2′-O-Methyl RNA/Ethylene-Bridged Nucleic Acid Chimera Antisense Oligonucleotides to Induce Dystrophin Exon 45 Skipping
por: Lee, Tomoko, et al.
Publicado: (2017)

Morpholino antisense oligonucleotides: tools for investigating vertebrate development
por: Corey, David R, et al.
Publicado: (2001)

MNA3.5 - Future Plans of the Open Source Software Initiative documented
Publicado: (Marc)

MNA3.6 - The use of EMI products by new user communities is documented
Publicado: (Marc)

Effects of 1-Methylnicotinamide (MNA) on Exercise Capacity and Endothelial Response in Diabetic Mice
por: Przyborowski, Kamil, et al.
Publicado: (2015)

Intramuscular Evaluation of Chimeric Locked Nucleic Acid/2′OMethyl-Modified Antisense Oligonucleotides for Targeted Exon 23 Skipping in Mdx Mice
por: Georgiadou, Michaella, et al.
Publicado: (2021)

Tween 85-Modified Low Molecular Weight PEI Enhances Exon-Skipping of Antisense Morpholino Oligomer In Vitro and in mdx Mice
por: Wang, Mingxing, et al.
Publicado: (2017)

Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3
por: Toonen, Lodewijk J. A., et al.
Publicado: (2016)

Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
por: Jirka, Silvana M G, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9ahvo021qn3t59grf14fjudq8t